Cooper C. Collins
CIK: 0001485508
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TXMD
TherapeuticsMD, Inc.
Director
Discretionary Trading P&L
Holdings
About Collins Cooper C.
Collins Cooper C. (SEC CIK 0001485508) files insider reports with the SEC as Director of TherapeuticsMD, Inc. (TXMD).
Signal8 holds 2 ownership filings by Collins Cooper C., all Form 4s, filed between Feb 20, 2025 and Nov 5, 2025. Those filings report 2 transactions, from Feb 18, 2025 to Nov 3, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Collins Cooper C.'s filings is in BOCA RATON, FL.
Recent filings by Collins Cooper C.
Other insiders filing for TherapeuticsMD, Inc. (TXMD)
- Thompson Tommy G, Director
- Naughton Gail K, Director
- Walker Marlan D, Chief Executive Officer